Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Moderate is a digital health company focused on reversing and managing metabolic conditions such as Type 2 diabetes and prediabetes through real-time data and artificial intelligence. The company utilizes Continuous Glucose Monitoring (CGM) hardware paired with a proprietary AI-driven mobile application to provide users with immediate feedback on how specific foods and lifestyle choices affect their blood sugar levels. By offering personalized nutritional insights and behavioral coaching, Moderate aims to help individuals achieve metabolic flexibility and long-term weight management. Their service is designed to bridge the gap between clinical data and daily habit formation for better metabolic outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on moderate.